Christopher Waddick
Financieel Directeur/CFO bij CARDIOL THERAPEUTICS INC.
Vermogen: 202 400 $ op 30-04-2024
Actieve functies van Christopher Waddick
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
CARDIOL THERAPEUTICS INC. | Directeur/Bestuurslid | 19-05-2022 | - |
Financieel Directeur/CFO | 16-08-2018 | - | |
Bedrijfssecretaris | 16-08-2018 | - | |
Active Energy, Inc.
Active Energy, Inc. Electric UtilitiesUtilities Active Energy, Inc. operates as an energy management firm. It offers energy assessment, electricity products and services, natural gas products and services, and cap and trade. The company is headquartered in Burlington, Canada. | Financieel Directeur/CFO | 01-01-2013 | - |
President | 01-01-2013 | - | |
Nrj Consulting, Inc. | President | 01-11-2009 | - |
Loopbaan van Christopher Waddick
Eerdere bekende functies van Christopher Waddick
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Vasogen, Inc.
Vasogen, Inc. Pharmaceuticals: MajorHealth Technology The Group's principal activities are research and commercialization of therapies designed to target the destructive inflammatory process associated with the development and progression of cardiovascular and neurodegenerative disorders. It's lead product, the Celacade System, is designed to activate the immune response to apoptosis - an important physiological process that regulates inflammation. Celacade has received European regulatory approval under the CE Mark for chronic heart failure and is currently being marketed in Europe by Grupo Ferrer Internacional, S.A. Celacade is also in late-stage development for the treatment of chronic heart failure in the United States. It is also developing a new class of drugs for the treatment of certain neuro-inflammatory disorders. VP025 is the lead drug candidate from this new class. | Algemeen Directeur | - | - |
Operationeel Directeur | 01-07-2005 | 01-06-2007 | |
Financieel Directeur/CFO | 01-06-2007 | 23-10-2009 |
Opleiding van Christopher Waddick
York University | Masters Business Admin |
Wilfrid Laurier University | Undergraduate Degree |
Statistieken
Internationaal
Canada | 6 |
Verenigde Staten | 2 |
Operationeel
Director of Finance/CFO | 3 |
President | 2 |
Chief Executive Officer | 1 |
Sectoraal
Health Technology | 3 |
Consumer Services | 3 |
Utilities | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
CARDIOL THERAPEUTICS INC. | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
Vasogen, Inc.
Vasogen, Inc. Pharmaceuticals: MajorHealth Technology The Group's principal activities are research and commercialization of therapies designed to target the destructive inflammatory process associated with the development and progression of cardiovascular and neurodegenerative disorders. It's lead product, the Celacade System, is designed to activate the immune response to apoptosis - an important physiological process that regulates inflammation. Celacade has received European regulatory approval under the CE Mark for chronic heart failure and is currently being marketed in Europe by Grupo Ferrer Internacional, S.A. Celacade is also in late-stage development for the treatment of chronic heart failure in the United States. It is also developing a new class of drugs for the treatment of certain neuro-inflammatory disorders. VP025 is the lead drug candidate from this new class. | Health Technology |
Active Energy, Inc.
Active Energy, Inc. Electric UtilitiesUtilities Active Energy, Inc. operates as an energy management firm. It offers energy assessment, electricity products and services, natural gas products and services, and cap and trade. The company is headquartered in Burlington, Canada. | Utilities |
Nrj Consulting, Inc. |
- Beurs
- Insiders
- Christopher Waddick
- Ervaring